What is the impact of the 2017 cochrane systematic review and meta-analysis that evaluated the use of PCSK9 inhibitors for lowering cardiovascular disease and mortality?
Year: 2018
Type: review
Authors: Mohamed A. Jalloh, Eric J. Ip, Shadi Doroudgar
Institution: Touro University California
Language: English
Subfield: Surgery
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2802231920